Support will also be needed for mass testing, for medical research, for deploying new treatments, and for producing, purchasing and distributing vaccines across the EU.
Parama taip pat bus reikalinga masiniams tyrimams, medicinos moksliniams tyrimams, naujiems gydymo būdams diegti ir vakcinoms gaminti, pirkti bei platinti visoje ES.